Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 50 min ago
PreprintAll rights reservedbioRxiv

Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses

2 more authors
  1. 1INSERM U955

Related

  1. A knockout screening platform for interferon-stimulated genes in respiratory cells identifies LY6E as a dominant antiviral effector against coronaviruses
    C. I. Stoddard, M. L. Litchford, K. Sung +7
    bioRxivPreprintCC BY-NC-NDFull textMicrobiologybioRxiv
  2. Structural mechanism of TRPC3 inhibition by a potent antagonist
    Jodie Collingridge, Bethan A. Cole, Molly A. Rowlett +4
    Journal of Biological ChemistryPeer-reviewedCC BY 4.0NeuroscienceCrossref
  3. A bivalent oral vaccine against Micropterus salmoides rhabdovirus and largemouth bass ranavirus based on yeast surface display technology
    Boge Gu, Pengzhen Yu, Hongyang Xu +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  4. A mutation-agnostic and allele-specific ASO strategy demonstrates potent functional rescue and retinal preservation in RHO-linked retinitis pigmentosa
    S. Spaag, W.-H. Wu, J. Yun +28
    bioRxivPreprintCC BY-NC-NDFull textGenetics & genomicsbioRxiv
  5. Discovery of potent anti-inflammatory flavonoid-sesquiterpenoid hybrids from Syzygium simile: Structure–activity relationships and nanomolar inhibition of human neutrophil activation
    Yu-Chun Lin, Ho-Cheng Wu, Tsong-Long Hwang +4
    Pharmaceutical BiologyPeer-reviewedCC BY 4.0Full textPlant biologyPMC
BibTeX
@misc{molina2026bivalent,
  title = {{Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses}},
  author = {D. Salomon Lopez Molina and N. Ahnou and R. Brillet and J.-G. Delcros and L. Softic and B. Jimenez Araya and M. Duval and M. Veruete and A. Bancet and D. Grenier and A. Mularoni and J.-M. Pawlotsky and I. Krimm and A. Ahmed-Belkacem},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.05.756735},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.05.756735v1},
}
RIS
TY  - UNPB
TI  - Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses
AU  - D. Salomon Lopez Molina
AU  - N. Ahnou
AU  - R. Brillet
AU  - J.-G. Delcros
AU  - L. Softic
AU  - B. Jimenez Araya
AU  - M. Duval
AU  - M. Veruete
AU  - A. Bancet
AU  - D. Grenier
AU  - A. Mularoni
AU  - J.-M. Pawlotsky
AU  - I. Krimm
AU  - A. Ahmed-Belkacem
PY  - 2026
DA  - 2026/10/05
PB  - bioRxiv
DO  - 10.64898/2026.10.05.756735
UR  - https://www.biorxiv.org/content/10.64898/2026.10.05.756735v1
ER  -